<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03562663</url>
  </required_header>
  <id_info>
    <org_study_id>BRC426</org_study_id>
    <nct_id>NCT03562663</nct_id>
  </id_info>
  <brief_title>Brain Stimulation and Robotics in Chronic Stroke Motor Recovery</brief_title>
  <official_title>Transcranial Direct Current Stimulation and Robotic Training in Chronic Stroke</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Burke Medical Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Beth Israel Deaconess Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Feinstein Institute for Medical Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Massachusetts Institute of Technology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Spaulding Rehabilitation Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Burke Medical Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Motor skill training and transcranial direct current stimulation (tDCS) have separately been&#xD;
      shown to alter cortical excitability and enhance motor function in humans. Their combination&#xD;
      is appealing for augmenting motor recovery in stroke patients, and this is an area presently&#xD;
      under heavy investigation globally. The investigators have previously shown that the timing&#xD;
      of tDCS application has functional significance, that tDCS applied prior to training can be&#xD;
      beneficial for voluntary behavior, and that tDCS effects may not simply be additive to&#xD;
      training effects, but may change the nature of the training effect. The investigators have&#xD;
      separately reported in a randomized-controlled clinical trial, that upper limb robotic&#xD;
      training alone over 12 weeks can improve clinical function of chronic stroke patients. Based&#xD;
      on our results with tDCS and robotic training, the investigators hypothesize that the same&#xD;
      repeated sessions of robotic training, but preceded by tDCS, would lead to a sustained and&#xD;
      functional change greater than robotic training alone. The investigators will determine if&#xD;
      clinical function can be improved and sustained with tDCS-robotic training and cortical&#xD;
      physiology changes that underlie functional improvements.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary aim of this study is to evaluate whether multiple sessions of combined tDCS and&#xD;
      robotic upper limb training in chronic hemiplegia, leads to clinical improvement in upperlimb&#xD;
      motor impairment. In chronic stroke patients (&gt;6months post-injury, stable unilateral motor&#xD;
      deficit) using a within-subjects repeated-measures design we will evaluate the effects of 12&#xD;
      weeks of robotic upperlimb training (3x/week, 36 sessions, shoulder/elbow/wrist in each&#xD;
      session) with real or sham tDCS before the robotic training. Clinical improvement will be&#xD;
      determined by a change in upper-limb Fugl-Meyer (primary), the Medical Research Council motor&#xD;
      power score (MRC), Wolf Motor Function Test, Barthel Index, and Stroke Impact Scale&#xD;
      (secondary) outcome measures following the training, and assessed again six months later.&#xD;
&#xD;
      The investigators further aim to identify and compare the neurophysiological characteristics&#xD;
      between intervention groups. The relationship between clinical improvement and&#xD;
      neurophysiological measures pertaining to robotic motor training following stroke are&#xD;
      presently not described in the literature. By measuring the EMG response from forearm&#xD;
      musculature to Transcranial Magnetic Stimulation the investigators will establish: (i)&#xD;
      plasticity associated with training, and (ii) the neurophysiological characteristics of&#xD;
      patients who respond to training. By understanding how brain excitability changes underpin&#xD;
      motor dysfunction, and motor recovery, interventions can be more effectively prescribed and&#xD;
      prognoses established.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 2012</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">January 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>We conducted a double-blind, sham-controlled, repeated-measures study design evaluating the effects of 12 weeks of robot-assisted upper-limb training (3x/week, 36 sessions) with tDCS (Robot-tDCS) or sham tDCS (Robot-Sham ) delivered at rest before each robot-assisted training session.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Care Provider, Outcomes Assessor)</masking>
    <masking_description>Staff delivering the transcranial direct current stimulation and performing evaluations are blinded to active vs. sham stimulation.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Change From Baseline in Upper Limb Fugl Meyer Score</measure>
    <time_frame>Baseline and after the 12-week intervention</time_frame>
    <description>Upper limb fugl Meyer score is a measure of upper extremity motor weakness on a 66-point scale.&#xD;
Fugl Meyer score range: 0-66. Higher scores indicate better outcome. Units: Units on a scale.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">82</enrollment>
  <condition>Chronic Stroke</condition>
  <arm_group>
    <arm_group_label>Active tDCS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in this group received 20 minutes of active 2 mA transcranial direct current stimulation over the motor cortex of the affected arm prior to robotic intervention.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham tDCS</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Participants in this group received 20 minutes of sham 2 mA transcranial direct current stimulation over the motor cortex of the affected arm prior to robotic training.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcranial direct current stimulation</intervention_name>
    <description>A constant, low current stimulation is provided non-invasively through sponge electrodes positioned over the motor cortex of the affected arm. The stimulation is provided for 20 minutes at an intensity of 2 mA.</description>
    <arm_group_label>Active tDCS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Upper extremity robotics</intervention_name>
    <description>Participants complete robotic training 3 days per week for 12 weeks, or 36 sessions. The protocol alternates between planar (shoulder/elbow) and wrist robots for the duration of the study.</description>
    <arm_group_label>Active tDCS</arm_group_label>
    <arm_group_label>Sham tDCS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  A first single focal unilateral lesion with diagnosis verified by brain imaging (MRI&#xD;
             or CT scans) that occurred at least 6 months prior;&#xD;
&#xD;
          -  Ability to follow 1-2 step commands&#xD;
&#xD;
          -  Fugl-Meyer assessment of 7 to 58 out of 66 (neither hemiplegic nor fully recovered&#xD;
             motor function in the muscles of the shoulder and elbow and wrist).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  A fixed contraction deformity in the affected limb;&#xD;
&#xD;
          -  A complete and total flaccid paralysis of all shoulder and elbow motor performance;&#xD;
&#xD;
          -  A hemorrhagic stroke&#xD;
&#xD;
          -  Presence of tDCS / TMS risk factors&#xD;
&#xD;
          -  Presence of an electrically, magnetically or mechanically activated implant (including&#xD;
             cardiac pacemaker), an intracerebral vascular clip, or any other electrically&#xD;
             sensitive support system&#xD;
&#xD;
          -  A history of medication-resistant epilepsy in the family&#xD;
&#xD;
          -  Past history of seizures or unexplained spells of loss of consciousness&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dylan Edwards, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Moss Rehabilitation Institute</affiliation>
  </overall_official>
  <reference>
    <citation>Heide G, Witte OW, Ziemann U. Physiology of modulation of motor cortex excitability by low-frequency suprathreshold repetitive transcranial magnetic stimulation. Exp Brain Res. 2006 May;171(1):26-34. Epub 2005 Nov 24.</citation>
    <PMID>16307247</PMID>
  </reference>
  <reference>
    <citation>Fitzgerald PB, Fountain S, Daskalakis ZJ. A comprehensive review of the effects of rTMS on motor cortical excitability and inhibition. Clin Neurophysiol. 2006 Dec;117(12):2584-96. Epub 2006 Aug 4. Review.</citation>
    <PMID>16890483</PMID>
  </reference>
  <reference>
    <citation>Fregni F, Boggio PS, Mansur CG, Wagner T, Ferreira MJ, Lima MC, Rigonatti SP, Marcolin MA, Freedman SD, Nitsche MA, Pascual-Leone A. Transcranial direct current stimulation of the unaffected hemisphere in stroke patients. Neuroreport. 2005 Sep 28;16(14):1551-5.</citation>
    <PMID>16148743</PMID>
  </reference>
  <reference>
    <citation>Hummel F, Celnik P, Giraux P, Floel A, Wu WH, Gerloff C, Cohen LG. Effects of non-invasive cortical stimulation on skilled motor function in chronic stroke. Brain. 2005 Mar;128(Pt 3):490-9. Epub 2005 Jan 5.</citation>
    <PMID>15634731</PMID>
  </reference>
  <reference>
    <citation>Iyer MB, Mattu U, Grafman J, Lomarev M, Sato S, Wassermann EM. Safety and cognitive effect of frontal DC brain polarization in healthy individuals. Neurology. 2005 Mar 8;64(5):872-5.</citation>
    <PMID>15753425</PMID>
  </reference>
  <reference>
    <citation>McCreery DB, Agnew WF, Yuen TG, Bullara L. Charge density and charge per phase as cofactors in neural injury induced by electrical stimulation. IEEE Trans Biomed Eng. 1990 Oct;37(10):996-1001.</citation>
    <PMID>2249872</PMID>
  </reference>
  <reference>
    <citation>Nitsche MA, Liebetanz D, Lang N, Antal A, Tergau F, Paulus W. Safety criteria for transcranial direct current stimulation (tDCS) in humans. Clin Neurophysiol. 2003 Nov;114(11):2220-2; author reply 2222-3.</citation>
    <PMID>14580622</PMID>
  </reference>
  <reference>
    <citation>Nitsche MA, Niehaus L, Hoffmann KT, Hengst S, Liebetanz D, Paulus W, Meyer BU. MRI study of human brain exposed to weak direct current stimulation of the frontal cortex. Clin Neurophysiol. 2004 Oct;115(10):2419-23.</citation>
    <PMID>15351385</PMID>
  </reference>
  <reference>
    <citation>Pascual-Leone A, Valls-Sol√© J, Wassermann EM, Hallett M. Responses to rapid-rate transcranial magnetic stimulation of the human motor cortex. Brain. 1994 Aug;117 ( Pt 4):847-58.</citation>
    <PMID>7922470</PMID>
  </reference>
  <reference>
    <citation>Priori A. Brain polarization in humans: a reappraisal of an old tool for prolonged non-invasive modulation of brain excitability. Clin Neurophysiol. 2003 Apr;114(4):589-95.</citation>
    <PMID>12686266</PMID>
  </reference>
  <reference>
    <citation>Talelli P, Rothwell J. Does brain stimulation after stroke have a future? Curr Opin Neurol. 2006 Dec;19(6):543-50. Review.</citation>
    <PMID>17102691</PMID>
  </reference>
  <reference>
    <citation>Tassinari CA, Cincotta M, Zaccara G, Michelucci R. Transcranial magnetic stimulation and epilepsy. Clin Neurophysiol. 2003 May;114(5):777-98. Review.</citation>
    <PMID>12738425</PMID>
  </reference>
  <reference>
    <citation>Volpe BT, Krebs HI, Hogan N. Robot-aided sensorimotor training in stroke rehabilitation. Adv Neurol. 2003;92:429-33. Review.</citation>
    <PMID>12760210</PMID>
  </reference>
  <reference>
    <citation>Volpe BT, Krebs HI, Hogan N, Edelsteinn L, Diels CM, Aisen ML. Robot training enhanced motor outcome in patients with stroke maintained over 3 years. Neurology. 1999 Nov 10;53(8):1874-6.</citation>
    <PMID>10563646</PMID>
  </reference>
  <reference>
    <citation>Ward NS, Cohen LG. Mechanisms underlying recovery of motor function after stroke. Arch Neurol. 2004 Dec;61(12):1844-8. Review.</citation>
    <PMID>15596603</PMID>
  </reference>
  <reference>
    <citation>Wassermann EM. Risk and safety of repetitive transcranial magnetic stimulation: report and suggested guidelines from the International Workshop on the Safety of Repetitive Transcranial Magnetic Stimulation, June 5-7, 1996. Electroencephalogr Clin Neurophysiol. 1998 Jan;108(1):1-16.</citation>
    <PMID>9474057</PMID>
  </reference>
  <reference>
    <citation>Webster BR, Celnik PA, Cohen LG. Noninvasive brain stimulation in stroke rehabilitation. NeuroRx. 2006 Oct;3(4):474-81. Review.</citation>
    <PMID>17012061</PMID>
  </reference>
  <reference>
    <citation>Yuen TG, Agnew WF, Bullara LA, Jacques S, McCreery DB. Histological evaluation of neural damage from electrical stimulation: considerations for the selection of parameters for clinical application. Neurosurgery. 1981 Sep;9(3):292-9.</citation>
    <PMID>7301072</PMID>
  </reference>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>June 8, 2018</study_first_submitted>
  <study_first_submitted_qc>June 8, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 19, 2018</study_first_posted>
  <results_first_submitted>July 10, 2019</results_first_submitted>
  <results_first_submitted_qc>December 28, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">January 20, 2021</results_first_posted>
  <last_update_submitted>December 28, 2020</last_update_submitted>
  <last_update_submitted_qc>December 28, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Burke Medical Research Institute</investigator_affiliation>
    <investigator_full_name>Dylan Edwards</investigator_full_name>
    <investigator_title>Lab Director, Laboratory for Non-Invasive Brain Stimulation and Human Motor Control</investigator_title>
  </responsible_party>
  <keyword>robotics</keyword>
  <keyword>transcranial direct current stimulation</keyword>
  <keyword>neurorehabilitation</keyword>
  <keyword>transcranial magnetic stimulation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>There is no plan to make individual participant data available to other researchers at this time.</ipd_description>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>CVA's identified (n=1600)&#xD;
Excluded on initial screen (n=859)&#xD;
425 with residential proximity to studying site contacted&#xD;
Excluded for the following reasons (n=343)&#xD;
Randomized (n=82)&#xD;
Robot Sham (n=41)&#xD;
Included in the post 6 months analysis (n=35)&#xD;
Robot tDCS (n=41)&#xD;
Included in the post 6 months analysis (n=34)</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Active tDCS</title>
          <description>Participants in this group received 20 minutes of active 2 mA transcranial direct current stimulation over the motor cortex of the affected arm prior to robotic intervention.&#xD;
Transcranial direct current stimulation: A constant, low current stimulation is provided non-invasively through sponge electrodes positioned over the motor cortex of the affected arm. The stimulation is provided for 20 minutes at an intensity of 2 mA.&#xD;
Upper extremity robotics: Participants complete robotic training 3 days per week for 12 weeks, or 36 sessions. The protocol alternates between planar (shoulder/elbow) and wrist robots for the duration of the study.</description>
        </group>
        <group group_id="P2">
          <title>Sham tDCS</title>
          <description>Participants in this group received 20 minutes of sham 2 mA transcranial direct current stimulation over the motor cortex of the affected arm prior to robotic training.&#xD;
Upper extremity robotics: Participants complete robotic training 3 days per week for 12 weeks, or 36 sessions. The protocol alternates between planar (shoulder/elbow) and wrist robots for the duration of the study.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="41"/>
                <participants group_id="P2" count="41"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="34"/>
                <participants group_id="P2" count="35"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Between January 2012 and January 2016, 82 participants with chronic stroke were enrolled in the study across the two sites (65 Site 1, 17 Site 2), and were randomized to Robot-tDCS (n = 41) or Robot-Sham (n = 41) groups.</population>
      <group_list>
        <group group_id="B1">
          <title>Active tDCS</title>
          <description>Participants in this group received 20 minutes of active 2 mA transcranial direct current stimulation over the motor cortex of the affected arm prior to robotic intervention.&#xD;
Transcranial direct current stimulation: A constant, low current stimulation is provided non-invasively through sponge electrodes positioned over the motor cortex of the affected arm. The stimulation is provided for 20 minutes at an intensity of 2 mA.&#xD;
Upper extremity robotics: Participants complete robotic training 3 days per week for 12 weeks, or 36 sessions. The protocol alternates between planar (shoulder/elbow) and wrist robots for the duration of the study.</description>
        </group>
        <group group_id="B2">
          <title>Sham tDCS</title>
          <description>Participants in this group received 20 minutes of sham 2 mA transcranial direct current stimulation over the motor cortex of the affected arm prior to robotic training.&#xD;
Upper extremity robotics: Participants complete robotic training 3 days per week for 12 weeks, or 36 sessions. The protocol alternates between planar (shoulder/elbow) and wrist robots for the duration of the study.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="41"/>
            <count group_id="B2" value="41"/>
            <count group_id="B3" value="82"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="66.0" lower_limit="61.0" upper_limit="73.0"/>
                    <measurement group_id="B2" value="70.0" lower_limit="64.0" upper_limit="77.0"/>
                    <measurement group_id="B3" value="68.5" lower_limit="62.0" upper_limit="76.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="32"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Time since stroke</title>
          <units>days</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1201" lower_limit="425" upper_limit="1693"/>
                    <measurement group_id="B2" value="654" lower_limit="365" upper_limit="1445"/>
                    <measurement group_id="B3" value="852.5" lower_limit="402.2" upper_limit="1594.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Fugl-Meyer score</title>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="22.0" lower_limit="11.0" upper_limit="43.0"/>
                    <measurement group_id="B2" value="21.5" lower_limit="9.0" upper_limit="42.0"/>
                    <measurement group_id="B3" value="21.8" lower_limit="10.0" upper_limit="42.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Upper Limb Fugl Meyer Score</title>
        <description>Upper limb fugl Meyer score is a measure of upper extremity motor weakness on a 66-point scale.&#xD;
Fugl Meyer score range: 0-66. Higher scores indicate better outcome. Units: Units on a scale.</description>
        <time_frame>Baseline and after the 12-week intervention</time_frame>
        <population>Of the 41 enrolled for active tDCS, 1 was lost due to unrelated illness and could not complete assessment after the 12-week intervention. Only 40 participant's data were included in the analysis. Of the 41 enrolled for Sham tDCS, 1 person was excluded due to Botox treatment, 2 people were excluded due to unrelated illness and 1 other person was excluded due to related illness. Only 37 participant's data were included in the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Active tDCS</title>
            <description>Participants in this group received 20 minutes of active 2 mA transcranial direct current stimulation over the motor cortex of the affected arm prior to robotic intervention.&#xD;
Transcranial direct current stimulation: A constant, low current stimulation is provided non-invasively through sponge electrodes positioned over the motor cortex of the affected arm. The stimulation is provided for 20 minutes at an intensity of 2 mA.&#xD;
Upper extremity robotics: Participants complete robotic training 3 days per week for 12 weeks, or 36 sessions. The protocol alternates between planar (shoulder/elbow) and wrist robots for the duration of the study.</description>
          </group>
          <group group_id="O2">
            <title>Sham tDCS</title>
            <description>Participants in this group received 20 minutes of sham 2 mA transcranial direct current stimulation over the motor cortex of the affected arm prior to robotic training.&#xD;
Upper extremity robotics: Participants complete robotic training 3 days per week for 12 weeks, or 36 sessions. The protocol alternates between planar (shoulder/elbow) and wrist robots for the duration of the study.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Upper Limb Fugl Meyer Score</title>
          <description>Upper limb fugl Meyer score is a measure of upper extremity motor weakness on a 66-point scale.&#xD;
Fugl Meyer score range: 0-66. Higher scores indicate better outcome. Units: Units on a scale.</description>
          <population>Of the 41 enrolled for active tDCS, 1 was lost due to unrelated illness and could not complete assessment after the 12-week intervention. Only 40 participant's data were included in the analysis. Of the 41 enrolled for Sham tDCS, 1 person was excluded due to Botox treatment, 2 people were excluded due to unrelated illness and 1 other person was excluded due to related illness. Only 37 participant's data were included in the analysis.</population>
          <units>Units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.0" spread="4.0"/>
                    <measurement group_id="O2" value="7.7" spread="4.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Active tDCS</title>
          <description>Participants in this group received 20 minutes of active 2 mA transcranial direct current stimulation over the motor cortex of the affected arm prior to robotic intervention.&#xD;
Transcranial direct current stimulation: A constant, low current stimulation is provided non-invasively through sponge electrodes positioned over the motor cortex of the affected arm. The stimulation is provided for 20 minutes at an intensity of 2 mA.&#xD;
Upper extremity robotics: Participants complete robotic training 3 days per week for 12 weeks, or 36 sessions. The protocol alternates between planar (shoulder/elbow) and wrist robots for the duration of the study.</description>
        </group>
        <group group_id="E2">
          <title>Sham tDCS</title>
          <description>Participants in this group received 20 minutes of sham 2 mA transcranial direct current stimulation over the motor cortex of the affected arm prior to robotic training.&#xD;
Upper extremity robotics: Participants complete robotic training 3 days per week for 12 weeks, or 36 sessions. The protocol alternates between planar (shoulder/elbow) and wrist robots for the duration of the study.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="41"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Headache</sub_title>
                <description>Headache</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Sleepiness</sub_title>
                <description>Sleepiness</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Trouble concentrating</sub_title>
                <description>Trouble concentrating</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Skin adverse event</sub_title>
                <description>Scalp burning sensation</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Skin adverse event</sub_title>
                <description>Tingling</description>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="41"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Skin adverse event</sub_title>
                <description>Skin redness</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dylan Edwards</name_or_title>
      <organization>Moss Rehabilitation Research Institute</organization>
      <phone>(215) 663-6411</phone>
      <email>EdwardDy@einstein.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

